Prestige Consumer Healthcare PBH
NYSE PBH
$51.31 +0.79 (+1.56%)
At close: Aug 21, 2026 · 4:00 PM EDT

Prestige Consumer Healthcare (PBH) Change in Intangibles (2014 - 2016)

Prestige Consumer Healthcare (PBH) posted quarterly Change in Intangibles of $1.0 million for Q2 2016, little changed year-over-year from $1.0 million in Q3 2015, and little changed quarter-over-quarter from $1.0 million in Q4 2015.

Prestige Consumer Healthcare (PBH) Change in Intangibles (2014 - 2016) Analysis & Trends

Prestige Consumer Healthcare's Change in Intangibles history runs 3 years deep, the most recent figure standing at $1.0 million for Q2 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -310.09 Mn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Prestige Consumer Healthcare 2.46 Bn 2.39 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2016 1.00 Mn
Jun 30, 2016 1.00 Mn
Dec 31, 2015 1.00 Mn
Dec 31, 2015 1.00 Mn
Sep 30, 2015 1.00 Mn
Sep 30, 2015 1.00 Mn
Jun 30, 2015 1.00 Mn
Jun 30, 2015 1.00 Mn
Dec 31, 2014 10.00 Mn
Dec 31, 2014 10.00 Mn